Chemistry: natural resins or derivatives; peptides or proteins; – Proteins – i.e. – more than 100 amino acid residues – Blood proteins or globulins – e.g. – proteoglycans – platelet...
Reexamination Certificate
2004-07-13
2009-10-20
Mertz, Prema (Department: 1646)
Chemistry: natural resins or derivatives; peptides or proteins;
Proteins, i.e., more than 100 amino acid residues
Blood proteins or globulins, e.g., proteoglycans, platelet...
C530S388100, C424S001490
Reexamination Certificate
active
07605234
ABSTRACT:
Specific binding members, featuring certain residues of the third CDR of the antibody NH576 (portions of SEQ ID NO:2) are provided, together with their use in methods of treatment and diagnosis.
REFERENCES:
patent: 4331647 (1982-05-01), Goldenberg
patent: 4361544 (1982-11-01), Goldenberg
patent: 4460559 (1984-07-01), Goldenberg
patent: 5019368 (1991-05-01), Epstein et al.
patent: 6017514 (2000-01-01), Epstein et al.
patent: 0 270 340 (1994-10-01), None
patent: WO97/25425 (1997-01-01), None
Marks, et al., “By-passing Immunization: Human Antibodies from V-gene Libraries Displayed on Phage” J. Mol. Biol. (1991) 222: 581-597.
Epstein et al., “Radioimmunodetection of Necrotic Lesions in Human Tumors Using 1-131 Labeled TNT-1 F(ab′)2Monoclonal Antibody” Antibody, Immunoconjugates, and Radiopharmaceuticals, vol. 4, No. 2, 1991, pp. 151-161.
Homick et al., “A new chemically modified chimeric TNT-3 monoclonal antibody directed against DNA for the radioimmunotherapy of solid tumors” Cancer Biotherapy and Radiopharmaceuticals, 13/4, 1998, 255-268.
Database EMBL , PIR2: “Accession No. S19663” Residues 1-109, XP002119494 (1993).
Database EMBL EMHUM3: “Accession No. Z14195, entry Hse54427” Residues 1-434 XP002119495 (1993).
Miller et al., “Immunologic and Biochemical Analysis of TNT-1 and TNT-2 Monoclonal Antibody Binding to Histones” Hybridoma, 12:689-98 XP002119491 cited in the application (1993).
Database EMBL, PIR2 “Accession No. S47184” Residues 1-109, XP002119493 (1995).
Desrues et al. “Monoclonal Antibody Po66 Uptake by Human Lung Tumours Implanted in Nude Mice: Effect of Co-Administration With Doxorubicin” British Journal of Cancer, 72:1076-1082, XP002119492 (1995).
King et al. “Preparation and Preclinical Evaluation of Humanised A33 Immunoconjugates for Radioimmunotherapy” British Journal of Cancer, 72:1364-1372, XP002911796 (1995).
Akiyama et al. “Cell Proliferation Kinetics of Human Gastric Carcinoma—A Quantitative Study of PCNA Expression Using a Color Image Analysis System” Database Biosis Online! Biosciences Information Service, Philadelphia, PA, 30:113-119, XP002119497 (1995).
Janhangir Sharifi et al., “Characterization of a Phage Display-Derived Human Monoclonal Antibody (NHS76) Counterpart to Chimeric TNT-1 Directed Against Necrotic Regions of Solid Tumors”, Hybridoma and Hybridomics, vol. 20, No. 5, pp. 305-312, (2001).
International Preliminary Examination Report for PCT/GB99/02123, International filing date Jul. 2, 1999.
Written Opinion for PCT/GB99/02123, International filing date Jul. 2, 1999.
Vaughan, et al., “Human Antibodies with Sub-nanomolar Affinities Isolated form a Large Non-immunized Phage Display Library”Nature Biotechnology(1996) 14: 309-314.
Search Report for European Patent Application No. 05010644.2.
Holtet Thor Las
Jackson Helen
Tempest Philip Ronald
Williams Andrew James
Knobbe Martens Olson & Bear LLP
Mertz Prema
Peregrine Pharmaceuticals, Inc.
LandOfFree
Specific binding proteins including antibodies which bind to... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Specific binding proteins including antibodies which bind to..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Specific binding proteins including antibodies which bind to... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4086866